← Back
$ACRS All transactions

Aclaris Therapeutics, Inc.

A

$ Value

$0

Shares

11,580

Price

$0

Filed

Jun 9

Insider

Name

GOWEN MAXINE

Title

CIK

0001280044

Roles

Director

Transaction Details

Transaction Date

2025-06-05

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

11,580

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. | The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 5, 2025, subject to the Reporting Person's Continuous Service (as defined in the Plan) through each such vesting date. | This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy. | The shares underlying these restricted stock units will vest in one installment on June 5, 2026, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date. | The shares underlying these restricted stock units vested on June 6, 2025.

Filing Info

Accession No.

0001415889-25-016248

Form Type

4

Issuer CIK

0001557746

GOWEN MAXINE's History

Date Ticker Type Value
2025-12-12 MRUS D $0
2025-12-12 MRUS D $0
2025-12-12 MRUS D $0
2025-12-12 MRUS D $0
2025-12-12 MRUS D $0
2025-12-12 MRUS D $0
2025-06-06 ACRS M
2025-06-06 ACRS M $0
2025-06-05 ACRS A $0
2025-06-05 ACRS A $0

Other Insiders at ACRS (90d)

Insider Bought Sold Last
Walker Neal
CEO
2026-02-03
Loerop James
Chief Business Officer
2026-02-03
Balthaser Kevin
Chief Financial Officer
2026-02-03
Davis Hugh M.
President and COO
2026-02-03
Hall Jesse Wayne
Chief Medical Officer
2026-02-02
Kolbeck Roland Wilhelm
Chief Scientific Officer
2026-02-02